Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.48
Delayed Data
As of Jan 20
 -0.02 / -0.36%
Today’s Change
5.45
Today|||52-Week Range
19.03
-2.14%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.50
Today’s open5.54
Day’s range5.46 - 5.64
Volume131,712
Average volume (3 months)254,259
Market cap$137.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+15.76%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.05-1.14%
VBIVVBI Vaccines Inc+0.07+2.07%
VBLTVascular Biogenics L...0.000.00%
AUPHAurinia Pharmaceutic...+0.05+2.02%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateApril 10, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs